Skip to main content
. 2022 Jul 13;44(6):729–737. doi: 10.1097/FTD.0000000000001006

TABLE 2.

Parameter Estimates of Final PK Model

Parameter Description Estimate %RSE Bootstrap Median (95% CI)
Structural model
CL/F=θ1(Age49)θ2(PODθ3inearlyphase)(PODθ4inlatephase)
  θ1,preop Oral clearance (CL/F) before surgery (L/h) in kidney transplant patients 21.9 12.2 22.3 (12.5,28.8)
  θ1,postop,kidney Baseline CL/F after surgery in kidney transplant patients (L/h) 20.5 5.9 20.3 (18.1,22.9)
  θ1.postop,liver Baseline CL/F after surgery in liver transplant patients (L/h) 12.9 17.9 12.7 (7.74,20.2)
  θ2 Age effect −0.397 27.7 −0.443 (−0.767, −0.191)
  θ3,kidney POD effect in early period in kidney transplant patient 0.112 13.3 0.107 (0.0748, 0.138)
  θ3,liver POD effect in liver transplant patient 0.0557 63.2 0.0589 (0.00161, 0.195)
  θ4,kidney POD effect in late period in kidney transplant patient −0.023 13.3 −0.0237 (−0.0506, −0.00148)
V/F=θ5(WT62.4)θ6
  θ5 Apparent volume (L) 499 12.2 482 (355, 647)
  θ5 Body weight effect 1.30 34.6 1.26 (0.0756, 2.29)
  ka Absorption rate constant 2.59 14.3 2.60 (1.96, 3.47)
  ALAG1 Lag time of first-order absorption 0.25 (fix)
Interindividual variability (CV%)
 ωCL/F Interindividual variability of CL/F 43.4 6.4 50.8 (39.7, 67.5)
 ωV/F Interindividual variability of V/F 84.2 11.9 89.6 (30.0, 118)
Correlation coefficients
 ρCL/F-V/F Correlation coefficients between CL/F and V/F 0.221 40.5 0.198 (0.0186, 0.281)
Residual error
 σadd, 1* Additive error 0.0001 (fix)
 σprop, 1* Proportional error 0.244 3.6 0.244 (0.227, 0.262)
 σadd, 2* Additive error −2.77 13.7 −2.91 (−3.5, −2.1)
 σadd, 3* Additive error 2.78 10.3 2.71 (2.34, 3.03)
*

Number refers to the hospital where data were collected (1: Seoul National University Hospital, 2: Inje University Busan Paik Hospital, 3: Chonnam National University Hospital).

PK, pharmacokinetics; POD, postoperative days; CI, confidential interval; CL, clearance; F, bioavailability; V, volume of distribution; WT, body weight.